White Paper

The Emergence of PROs in Oncology

When a Lethal Disease Becomes Chronic

Read more

Now that oncology patients are surviving longer, survival rate alone is insufficient for novel therapy evaluations. Patient-reported outcomes (PROs) offer an improved option for research outcomes. Check out this comprehensive and actionable guide for integrating PROs into your oncology trial.

Key Takeaways:

  • Regulatory Shifts: How PROs are shaping regulatory agency directives
  • Trial Harmonization: The role of PROs in streamlining global clinical trials
  • Economic Impact: PROs’ influence on payor reimbursement strategies
  • Patient-Centered Approach: Prioritizing the patient’s perspective for better outcomes
  • Best Practices: Strategies for effective PRO integration in clinical trials

Authors:

Chief Medical and Scientific Officer
Matthew Confeld, PharmD, PhD
Assistant Director, Clinical Research Methodology

Want to learn more about Worldwide Clinical Trials?